MARC details
000 -LEADER |
fixed length control field |
05823naaaa2201537uu 4500 |
001 - CONTROL NUMBER |
control field |
https://directory.doabooks.org/handle/20.500.12854/68416 |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20220714181031.0 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
books978-3-0365-0221-2 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9783036502205 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9783036502212 |
024 7# - OTHER STANDARD IDENTIFIER |
Standard number or code |
10.3390/books978-3-0365-0221-2 |
Terms of availability |
doi |
041 0# - LANGUAGE CODE |
Language code of text/sound track or separate title |
English |
042 ## - AUTHENTICATION CODE |
Authentication code |
dc |
072 #7 - SUBJECT CATEGORY CODE |
Subject category code |
M |
Source |
bicssc |
100 1# - MAIN ENTRY--PERSONAL NAME |
Personal name |
Pereira, Maria Carmo |
Relator code |
edt |
9 (RLIN) |
1598032 |
245 10 - TITLE STATEMENT |
Title |
PLGA Based Drug Carrier and Pharmaceutical Applications |
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
Place of publication, distribution, etc |
Basel, Switzerland |
Name of publisher, distributor, etc |
MDPI - Multidisciplinary Digital Publishing Institute |
Date of publication, distribution, etc |
2021 |
300 ## - PHYSICAL DESCRIPTION |
Extent |
1 electronic resource (328 p.) |
506 0# - RESTRICTIONS ON ACCESS NOTE |
Terms governing access |
Open Access |
Source of term |
star |
Standardized terminology for access restriction |
Unrestricted online access |
520 ## - SUMMARY, ETC. |
Summary, etc |
Poly(lactic-co-glycolic acid) (PLGA) is one of the most successful polymers used for producing therapeutic devices, such as drug carriers (DC). PLGA is one of the few polymers that the Food and Drug Administration (FDA) has approved for human administration due to its biocompatibility and biodegradability. In recent years, DC produced with PLGA has gained enormous attention for its versatility in transporting different type of drugs, e.g., hydrophilic or hydrophobic small molecules, or macromolecules with a controlled drug release without modifying the physiochemical properties of the drugs. These drug delivery systems have the possibility/potential to modify their surface properties with functional groups, peptides, or other coatings to improve the interactions with biological materials. Furthermore, they present the possibility to be conjugated with specific target molecules to reach specific tissues or cells. They are also used for different therapeutic applications, such as in vaccinations, cancer treatment, neurological disorder treatment, and as anti-inflammatory agents. This book aims to focus on the recent progress of PLGA as a drug carrier and their new pharmaceutical applications. |
540 ## - TERMS GOVERNING USE AND REPRODUCTION NOTE |
Terms governing use and reproduction |
Creative Commons |
-- |
https://creativecommons.org/licenses/by/4.0/ |
-- |
cc |
-- |
https://creativecommons.org/licenses/by/4.0/ |
546 ## - LANGUAGE NOTE |
Language note |
English |
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Medicine |
Source of heading or term |
bicssc |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
PLGA |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
nanoscaled drug delivery |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
LED |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
cancer |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
serum stability |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
reactive oxygen species |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
cellular uptake |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
terahertz spectroscopy |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
microspheres |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
drug delivery |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
formulation development |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
molecular mobility |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
vitamin E |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
tocopherol |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
PLA |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
core-shell nanoparticles |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
controlled drug release |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
BMP-2 |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
PLGA nanoparticles |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
Pluronic F68 |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
oxaliplatin |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
hydrogel |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
intra-abdominal anti-adhesion barrier |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
colorectal cancer |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
experimental design |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
fractional factorial design |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
O6-methylguanine DNA methyltransferase (MGMT) protein |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
glioblastoma multiforme |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
smart nanocarriers |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
folic acid |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
verteporfin |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
cisplatin |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
SKOV-3 cells |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
CHO-K1 cells |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
electroporation |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
theranostic cargo |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
double emulsion approach |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
NSAIDs |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
polymeric film |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
topical drug delivery |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
trolamine salicylate |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
triamcinolone acetonide |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
microcrystal |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
PLGA microsphere |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
local delivery |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
spray-drying technique |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
intra-articular injection |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
joint retention |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
systemic exposure |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
gadolinium |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
drug release |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
polymeric nanocarrier |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
sorafenib |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
theranostic nanoparticles |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
PLGA-PEG |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
nanoparticles |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
platelet |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
activation |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
aggregation |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
binding |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
uptake |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
tissue engineering |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
Huntington's disease |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
siRNA |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
microcarriers |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
mesenchymal stromal cells |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
drug delivery systems |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
microfluidics |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
microparticles |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
BMP-2-microspheres |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
hydrogel system |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
17-βestradiol release |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
bone regeneration |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
osteoporosis |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
poly-lactide-co-glycolide |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
polylactic acid |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
alginate |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
ophthalmic drug delivery |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
dexamethasone |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
PLGA-NPs |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
nanomedicine |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
gastrointestinal tract |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
paclitaxel |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
in vivo imaging |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
controlled release |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
risperidone |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
microcapsules |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
oleogels |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
electron microscopy |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
three-dimensional X-ray imaging |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
nano-CT |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
biodegradable polymers |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
hydroxy-stearic acid |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
PLGA nanocapsules |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
magnetic resonance imaging |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
photoluminescence |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
magnetic targeting |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
multimodal imaging |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
theranostics |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
silicon |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
microsphere |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
n/a |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Loureiro, Joana |
Relator code |
edt |
9 (RLIN) |
1598033 |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Pereira, Maria Carmo |
Relator code |
oth |
9 (RLIN) |
1598032 |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Loureiro, Joana |
Relator code |
oth |
9 (RLIN) |
1598033 |
856 40 - ELECTRONIC LOCATION AND ACCESS |
Host name |
www.oapen.org |
Uniform Resource Identifier |
<a href="https://mdpi.com/books/pdfview/book/3432">https://mdpi.com/books/pdfview/book/3432</a> |
-- |
0 |
Public note |
DOAB: download the publication |
856 40 - ELECTRONIC LOCATION AND ACCESS |
Host name |
www.oapen.org |
Uniform Resource Identifier |
<a href="https://directory.doabooks.org/handle/20.500.12854/68416">https://directory.doabooks.org/handle/20.500.12854/68416</a> |
-- |
0 |
Public note |
DOAB: description of the publication |